We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Author Title [ Type(Desc)] Year
Filters: Keyword is Neuromuscular Blocking Agents and Author is Savarese, J J  [Clear All Filters]
Journal Article
Goudsouzian NG, Savarese JJ.  1994.  Antagonizing residual neuromuscular block with neostigmine and atropine.. Br J Anaesth. 73(5):725.
Scott RP, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG.  1985.  Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response.. Br J Anaesth. 57(6):550-3.
Savarese JJ, Philbin DM.  1979.  Cardiovascular effects of neuromuscular blocking agents.. Int Anesthesiol Clin. 17(1):13-54.
Scott RP, Savarese JJ, Basta SJ, Embree P, Ali HH, Sunder N, Hoaglin DC.  1986.  Clinical pharmacology of atracurium given in high dose.. Br J Anaesth. 58(8):834-8.
Savarese JJ, Ali HH, Basta SJ, Sunder N, Moss J, Gionfriddo MA, Lineberry CG, Wastila WB, el-Sayad HA, Montague D et al..  1983.  The clinical pharmacology of BW A444U. A nondepolarizing ester relaxant of intermediate duration.. Anesthesiology. 58(4):333-41.
Savarese JJ.  1986.  Clinical relaxation: current controversy.. Can Anaesth Soc J. 33(3 Pt 2):S1-4.
Lebowitz PW, Ramsey FM, Savarese JJ, Ali HH, deBros FM.  1981.  Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone.. Anesth Analg. 60(1):12-7.
Lebowitz PW, Savarese JJ.  1980.  Complications involving neuromuscular pharmacology.. Int Anesthesiol Clin. 18(3):139-56.
Ali HH, Wilson RS, Savarese JJ, Kitz RJ.  1975.  The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans.. Br J Anaesth. 47(5):570-4.
Ali HH, Savarese JJ, Basta SJ, Sunder N, Gionfriddo M.  1983.  Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.. Br J Anaesth. 55 Suppl 1:107S-111S.
Moss J, Philbin DM, Rosow CE, Basta SJ, Gelb C, Savarese JJ.  1982.  Histamine release by neuromuscular blocking agents in man.. Klin Wochenschr. 60(17):891-5.
Basta SJ, Savarese JJ, Ali HH, Moss J, Gionfriddo M.  1983.  Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine.. Br J Anaesth. 55 Suppl 1:105S-106S.
Savarese JJ.  1979.  How may neuromuscular blocking drugs affect the state of general anesthesia? Anesth Analg. 58(6):449-51.
Donlon JV, Savarese JJ, Ali HH, Teplik RS.  1980.  Human dose-response curves for neuromuscular blocking drugs: a comparison of two methods of construction and analysis.. Anesthesiology. 53(2):161-6.
Ali HH, Savarese JJ.  1976.  Monitoring of neuromuscular function.. Anesthesiology. 45(2):216-49.
Mitchell MM, Ali HH, Savarese JJ.  1978.  Myotonia and neuromuscular blocking agents.. Anesthesiology. 49(1):44-8.
Savarese JJ.  1981.  The new neuromuscular blocking drugs are here.. Anesthesiology. 55(1):1-3.
Lebowitz PW, Ramsey FM, Savarese JJ, Ali HH.  1980.  Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.. Anesth Analg. 59(8):604-9.
Savarese JJ, Kitz RJ.  1973.  The quest for a short-acting nondepolarizing neuromuscular blocking agent.. Acta Anaesthesiol Scand Suppl. 53:43-58.